Nyxoah (NYXH)
(Delayed Data from NSDQ)
$7.25 USD
-0.21 (-2.82%)
Updated Aug 6, 2025 03:59 PM ET
After-Market: $7.25 0.00 (0.00%) 5:44 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
NYXH 7.25 -0.21(-2.82%)
Will NYXH be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NYXH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NYXH
Nyxoah SA (NYXH) Reports Q1 Loss, Lags Revenue Estimates
Claritev Corporation (CTEV) Reports Q1 Loss, Tops Revenue Estimates
NYXH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Health Catalyst (HCAT) Q1 Earnings Meet Estimates
Clover Health Investments, Corp. (CLOV) Surpasses Q1 Earnings Estimates
Nyxoah SA (NYXH) Reports Q4 Loss, Lags Revenue Estimates
Other News for NYXH
Information on the total number of voting rights and shares | NYXH Stock News
Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025 | NYXH Stock News
Nyxoah's DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine | NYXH ...
Nyxoah publishes DREAM study data in Journal of Clinical Sleep Medicine
Nyxoah SA Announces New Share Issuance to Strengthen Financial Structure